We are Developing and Moving Forward•••

• January 2022

  Signed contracts for and carried out CDMO projects, with many projects under discussion

• December 2021

  Completed utility systems, production qualification and engineering runs for protein production in Taicang facilities; The team members in BioInno exceeded 100 employees

• November 2021

  Completed round A financing； Hangzhou Tailong Capital and China Industrial International Trust Limited jointly led the investment; production capacity of Taicang facilities greatly increased

• May 2021

  Equipment for Taicang facilities arrived at the site

• February 2021

  Completed the Pre-A round of financing; Tigermed and TigerYear Capital led investment

• October 2020

  Installation of Taicang facilities started; Suzhou R&D laboratory construction started

• July 2020

  Angel round financing led to the strategic investment of TigerYear Capital (Tigermed Fund)

• February 2020

  With the support from local government, BioInno settled in Taicang Biomedical Industrial Park, started design for BioInno facilities with 12,000 square meters, and reserved 7 hectares industrial land for future development.

• November 2019

  BioInno Bioscience was founded